Suppr超能文献

与9p21.3相关的晚发性阿尔茨海默病家族的连锁与关联研究。

Linkage and association study of late-onset Alzheimer disease families linked to 9p21.3.

作者信息

Züchner S, Gilbert J R, Martin E R, Leon-Guerrero C R, Xu P-T, Browning C, Bronson P G, Whitehead P, Schmechel D E, Haines J L, Pericak-Vance M A

机构信息

Miami Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.

出版信息

Ann Hum Genet. 2008 Nov;72(Pt 6):725-31. doi: 10.1111/j.1469-1809.2008.00474.x. Epub 2008 Aug 28.

Abstract

A chromosomal locus for late-onset Alzheimer disease (LOAD) has previously been mapped to 9p21.3. The most significant results were reported in a sample of autopsy-confirmed families. Linkage to this locus has been independently confirmed in AD families from a consanguineous Israeli-Arab community. In the present study we analyzed an expanded clinical sample of 674 late-onset AD families, independently ascertained by three different consortia. Sample subsets were stratified by site and autopsy-confirmation. Linkage analysis of a dense array of SNPs across the chromosomal locus revealed the most significant results in the 166 autopsy-confirmed families of the NIMH sample. Peak HLOD scores of 4.95 at D9S741 and 2.81 at the nearby SNP rs2772677 were obtained in a dominant model. The linked region included the cyclin-dependent kinase inhibitor 2A gene (CDKN2A), which has been suggested as an AD candidate gene. By re-sequencing all exons in the vicinity of CDKN2A in 48 AD cases, we identified and genotyped four novel SNPs, including a non-synonymous, a synonymous, and two variations located in untranslated RNA sequences. Family-based allelic and genotypic association analysis yielded significant results in CDKN2A (rs11515: PDT p = 0.003, genotype-PDT p = 0.014). We conclude that CDKN2A is a promising new candidate gene potentially contributing to AD susceptibility on chromosome 9p.

摘要

迟发性阿尔茨海默病(LOAD)的一个染色体位点先前已被定位到9p21.3。在经尸检确诊的家系样本中报告了最显著的结果。在一个有血缘关系的以色列 - 阿拉伯社区的AD家系中,已独立证实与该位点存在连锁关系。在本研究中,我们分析了由三个不同联盟独立确定的674个迟发性AD家系的扩大临床样本。样本子集按地点和尸检确诊情况进行分层。对该染色体位点上密集的单核苷酸多态性(SNP)阵列进行连锁分析,在NIMH样本的166个经尸检确诊的家系中得到了最显著的结果。在显性模型中,D9S741处的最高全基因组连锁优势对数(HLOD)得分是4.95,附近的SNP rs2772677处为2.81。连锁区域包括细胞周期蛋白依赖性激酶抑制剂2A基因(CDKN2A),该基因已被认为是一个AD候选基因。通过对48例AD病例中CDKN2A附近的所有外显子进行重测序,我们鉴定并对四个新的SNP进行了基因分型,包括一个非同义、一个同义以及两个位于非翻译RNA序列中的变异。基于家系的等位基因和基因型关联分析在CDKN2A中产生了显著结果(rs11515:传递不平衡检验(PDT)p = 0.003,基因型 - PDT p = 0.014)。我们得出结论,CDKN2A是一个有前景的新候选基因,可能对9号染色体上的AD易感性有贡献。

相似文献

1
Linkage and association study of late-onset Alzheimer disease families linked to 9p21.3.
Ann Hum Genet. 2008 Nov;72(Pt 6):725-31. doi: 10.1111/j.1469-1809.2008.00474.x. Epub 2008 Aug 28.
2
Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22.
Am J Hum Genet. 2003 Nov;73(5):1041-51. doi: 10.1086/379083. Epub 2003 Oct 16.
4
A genomewide screen for late-onset Alzheimer disease in a genetically isolated Dutch population.
Am J Hum Genet. 2007 Jul;81(1):17-31. doi: 10.1086/518720. Epub 2007 May 29.
6
Covariate analysis of late-onset Alzheimer disease refines the chromosome 12 locus.
Mol Psychiatry. 2006 Mar;11(3):280-5. doi: 10.1038/sj.mp.4001766.
9
Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B.
Atherosclerosis. 2012 Feb;220(2):449-55. doi: 10.1016/j.atherosclerosis.2011.11.017. Epub 2011 Nov 19.
10
Evidence of linkage and association on chromosome 20 for late-onset Alzheimer disease.
Neurogenetics. 2004 Jun;5(2):121-8. doi: 10.1007/s10048-004-0174-3. Epub 2004 Mar 19.

引用本文的文献

3
Methyltransferase Inhibition Enables Tgf Driven Induction of and in Cancer Cells.
Mol Cell Biol. 2023;43(3):115-129. doi: 10.1080/10985549.2023.2186074.
4
Co-expression network analysis of frontal cortex during the progression of Alzheimer's disease.
Cereb Cortex. 2022 Nov 9;32(22):5108-5120. doi: 10.1093/cercor/bhac001.
5
LncRNA functional annotation with improved false discovery rate achieved by disease associations.
Comput Struct Biotechnol J. 2021 Dec 16;20:322-332. doi: 10.1016/j.csbj.2021.12.016. eCollection 2022.
7
Gene Expression as a Potential Aging Biomarker in Dogs.
Front Vet Sci. 2021 Apr 26;8:660435. doi: 10.3389/fvets.2021.660435. eCollection 2021.
8
Identifying Blood Transcriptome Biomarkers of Alzheimer's Disease Using Transgenic Mice.
Mol Neurobiol. 2020 Dec;57(12):4941-4951. doi: 10.1007/s12035-020-02058-2. Epub 2020 Aug 20.
9
The Role of BMI1 in Late-Onset Sporadic Alzheimer's Disease.
Genes (Basel). 2020 Jul 21;11(7):825. doi: 10.3390/genes11070825.

本文引用的文献

1
SNPselector: a web tool for selecting SNPs for genetic association studies.
Bioinformatics. 2005 Nov 15;21(22):4181-6. doi: 10.1093/bioinformatics/bti682. Epub 2005 Sep 22.
2
The expression of cell cycle proteins in neurons and its relevance for Alzheimer's disease.
Curr Drug Targets CNS Neurol Disord. 2005 Jun;4(3):293-306. doi: 10.2174/1568007054038175.
4
Genotype-based association test for general pedigrees: the genotype-PDT.
Genet Epidemiol. 2003 Nov;25(3):203-13. doi: 10.1002/gepi.10258.
5
Alzheimer disease in the US population: prevalence estimates using the 2000 census.
Arch Neurol. 2003 Aug;60(8):1119-22. doi: 10.1001/archneur.60.8.1119.
6
Cyclin C expression is involved in the pathogenesis of Alzheimer's disease.
Neurobiol Aging. 2003 May-Jun;24(3):427-35. doi: 10.1016/s0197-4580(02)00132-x.
7
Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community.
Hum Mol Genet. 2003 Feb 15;12(4):415-22. doi: 10.1093/hmg/ddg037.
8
Results of a high-resolution genome screen of 437 Alzheimer's disease families.
Hum Mol Genet. 2003 Jan 1;12(1):23-32. doi: 10.1093/hmg/ddg007.
9
Full genome screen for Alzheimer disease: stage II analysis.
Am J Med Genet. 2002 Mar 8;114(2):235-44. doi: 10.1002/ajmg.10183.
10
Identification of novel genes in late-onset Alzheimer's disease.
Exp Gerontol. 2000 Dec;35(9-10):1343-52. doi: 10.1016/s0531-5565(00)00196-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验